{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T03:36:03Z","timestamp":1784345763339,"version":"3.55.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T00:00:00Z","timestamp":1753142400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T00:00:00Z","timestamp":1753142400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Kakenhi","doi-asserted-by":"crossref","award":["24K11898"],"award-info":[{"award-number":["24K11898"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Surg Today"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s00595-025-03100-3","type":"journal-article","created":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T23:30:55Z","timestamp":1753140655000},"page":"1347-1352","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Living donor liver transplantation using ABO-incompatible grafts for chronic and acute liver failure"],"prefix":"10.1007","volume":"55","author":[{"given":"Toru","family":"Ikegami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Tsunematsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenei","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Onda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michinori","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Shirai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichiro","family":"Haruki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,22]]},"reference":[{"issue":"1","key":"3100_CR1","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/ajt.12520","volume":"14","author":"H Egawa","year":"2014","unstructured":"Egawa H, Teramukai S, Haga H, Tanabe M, Mori A, Ikegami T, et al. Impact of rituximab desensitization on blood-type-incompatible adult living donor liver transplantation: a Japanese multicenter study. Am J Transplant. 2014;14(1):102\u201314.","journal-title":"Am J Transplant"},{"issue":"3","key":"3100_CR2","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s00595-010-4437-3","volume":"41","author":"V Raut","year":"2011","unstructured":"Raut V, Uemoto S. Management of ABO-incompatible living-donor liver transplantation: past and present trends. Surg Today. 2011;41(3):317\u201322.","journal-title":"Surg Today"},{"issue":"10","key":"3100_CR3","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1007\/s00595-023-02678-w","volume":"53","author":"K Hirukawa","year":"2023","unstructured":"Hirukawa K, Shinoda M, Hasegawa Y, Obara H, Kitago M, Yagi H, et al. Long-term outcomes following ABO-incompatible living donor liver transplantation for acute liver failure: a single-center experience of over 20 years. Surg Today. 2023;53(10):1160\u201372.","journal-title":"Surg Today"},{"issue":"4","key":"3100_CR4","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.hbpd.2020.06.017","volume":"19","author":"H Egawa","year":"2020","unstructured":"Egawa H. Challenge to ABO blood type barrier in living donor liver transplantation. Hepatobiliary Pancreat Dis Int. 2020;19(4):342\u20138.","journal-title":"Hepatobiliary Pancreat Dis Int"},{"issue":"12","key":"3100_CR5","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1097\/00007890-200206270-00021","volume":"73","author":"M Tanabe","year":"2002","unstructured":"Tanabe M, Shimazu M, Wakabayashi G, Hoshino K, Kawachi S, Kadomura T, et al. Intraportal infusion therapy as a novel approach to adult ABO-incompatible liver transplantation. Transplantation. 2002;73(12):1959\u201361.","journal-title":"Transplantation"},{"issue":"3","key":"3100_CR6","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1097\/TP.0b013e3181adcae6","volume":"88","author":"T Ikegami","year":"2009","unstructured":"Ikegami T, Taketomi A, Soejima Y, Yoshizumi T, Uchiyama H, Harada N, et al. Rituximab, IVIG, and plasma exchange without graft local infusion treatment: a new protocol in ABO incompatible living donor liver transplantation. Transplantation. 2009;88(3):303\u20137.","journal-title":"Transplantation"},{"key":"3100_CR7","unstructured":"Usui M, Isaji S, Mizuno S, Sakurai H, Uemoto S. Experiences and problems pre-operative anti-CD20 monoclonal antibody infusion therapy with splenectomy and plasma exchange for ABO-incompatible living-donor liver transplantation."},{"issue":"2","key":"3100_CR8","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1097\/TP.0000000000004250","volume":"107","author":"H Egawa","year":"2023","unstructured":"Egawa H, Ohdan H, Saito K. Current status of ABO-incompatible liver transplantation. Transplantation. 2023;107(2):313\u201325.","journal-title":"Transplantation"},{"issue":"9","key":"3100_CR9","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1111\/hepr.13364","volume":"49","author":"K Umeshita","year":"2019","unstructured":"Umeshita K, Eguchi S, Egawa H, Haga H, Kasahara M, Kokudo N, et al. Liver transplantation in Japan: Registry by the Japanese Liver Transplantation Society. Hepatol Res. 2019;49(9):964\u201380.","journal-title":"Hepatol Res"},{"issue":"9","key":"3100_CR10","doi-asserted-by":"publisher","first-page":"2526","DOI":"10.1111\/j.1600-6143.2012.04126.x","volume":"12","author":"F Paterno","year":"2012","unstructured":"Paterno F, Shiller, Tillery MG, O\u2019Leary JG, Susskind B, Trotter J, et al. Bortezomib for acute antibody-mediated rejection in liver transplantation. Am J Transplant. 2012;12(9):2526\u201331.","journal-title":"Am J Transplant"},{"issue":"1","key":"3100_CR11","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1097\/TP.0000000000001956","volume":"102","author":"H Yamamoto","year":"2018","unstructured":"Yamamoto H, Uchida K, Kawabata S, Isono K, Miura K, Hayashida S, et al. Feasibility of monotherapy by rituximab without additional desensitization in ABO-incompatible living-donor liver transplantation. Transplantation. 2018;102(1):97\u2013104.","journal-title":"Transplantation"},{"issue":"2","key":"3100_CR12","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/ctr.12060","volume":"27","author":"Y Soejima","year":"2013","unstructured":"Soejima Y, Muto J, Matono R, Ninomiya M, Ikeda T, Yoshizumi T, et al. Strategic breakthrough in adult ABO-incompatible living donor liver transplantation: preliminary results of consecutive seven cases. Clin Transplant. 2013;27(2):227\u201331.","journal-title":"Clin Transplant"},{"issue":"1","key":"3100_CR13","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1097\/TP.0b013e318239e8e4","volume":"93","author":"V Raut","year":"2012","unstructured":"Raut V, Mori A, Kaido T, Ogura Y, Taku I, Nagai K, et al. Splenectomy does not offer immunological benefits in ABO-incompatible liver transplantation with a preoperative rituximab. Transplantation. 2012;93(1):99\u2013105.","journal-title":"Transplantation."},{"issue":"10","key":"3100_CR14","doi-asserted-by":"publisher","first-page":"3491","DOI":"10.1016\/j.transproceed.2007.09.028","volume":"39","author":"T Ikegami","year":"2007","unstructured":"Ikegami T, Taketomi A, Soejima Y, Iguchi T, Sanefuji K, Kayashima H, et al. Successful ABO incompatible living donor liver transplantation in a patient with high isoagglutinin titer using high-dose intravenous immunoglobulin. Transplant Proc. 2007;39(10):3491\u20134.","journal-title":"Transplant Proc"},{"issue":"4","key":"3100_CR15","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/S1499-3872(14)60268-X","volume":"13","author":"T Shen","year":"2014","unstructured":"Shen T, Lin BY, Jia JJ, Wang ZY, Wang L, Ling Q, et al. A modified protocol with rituximab and intravenous immunoglobulin in emergent ABO-incompatible liver transplantation for acute liver failure. Hepatobiliary Pancreat Dis Int. 2014;13(4):395\u2013401.","journal-title":"Hepatobiliary Pancreat Dis Int"},{"issue":"2","key":"3100_CR16","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1046\/j.1365-2230.2001.00779.x","volume":"26","author":"S Jolles","year":"2001","unstructured":"Jolles S. A review of high-dose intravenous immunoglobulin (hdIVIg) in the treatment of the autoimmune blistering disorders. Clin Exp Dermatol. 2001;26(2):127\u201331.","journal-title":"Clin Exp Dermatol"},{"issue":"9","key":"3100_CR17","first-page":"CD002063","volume":"2014","author":"RA Hughes","year":"2014","unstructured":"Hughes RA, Swan AV, van Doorn PA. Intravenous immunoglobulin for Guillain-Barre syndrome. Cochrane Database Syst Rev. 2014;2014(9):CD002063.","journal-title":"Cochrane Database Syst Rev"},{"issue":"Suppl 1","key":"3100_CR18","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1007\/s100720200011","volume":"23","author":"B Ferrero","year":"2002","unstructured":"Ferrero B, Durelli L. High-dose intravenous immunoglobulin G treatment of myasthenia gravis. Neurol Sci. 2002;23(Suppl 1):S9-24.","journal-title":"Neurol Sci"},{"issue":"2","key":"3100_CR19","doi-asserted-by":"publisher","first-page":"e12","DOI":"10.1111\/tri.12015","volume":"26","author":"J Belli\u00e8re","year":"2013","unstructured":"Belli\u00e8re J, Rostaing L, Guilbeau-Frugier C, Congy N, Kamar N. Low- versus high-dose rituximab for antibody-mediated rejection after kidney transplantation. Transpl Int. 2013;26(2):e12\u20134.","journal-title":"Transpl Int"},{"issue":"9","key":"3100_CR20","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1080\/14740338.2018.1513487","volume":"17","author":"G Cengiz Seval","year":"2018","unstructured":"Cengiz Seval G, Beksac M. The safety of bortezomib for the treatment of multiple myeloma. Expert Opin Drug Saf. 2018;17(9):953\u201362.","journal-title":"Expert Opin Drug Saf"},{"issue":"3","key":"3100_CR21","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.14555","volume":"36","author":"WC Lee","year":"2022","unstructured":"Lee WC, Cheng CH, Lee CF, Hung HC, Lee JC, Wu TH, et al. Quick preparation of ABO-incompatible living donor liver transplantation for acute liver failure. Clin Transplant. 2022;36(3): e14555.","journal-title":"Clin Transplant"},{"issue":"1","key":"3100_CR22","doi-asserted-by":"publisher","first-page":"128","DOI":"10.4103\/ajts.ajts_55_21","volume":"17","author":"JJ Valamparampil","year":"2023","unstructured":"Valamparampil JJ, Sachan D, Shanmugam N, Reddy SM, Rela M. Emergency ABO-incompatible living donor liver transplantation in Wilson disease-induced acute liver failure. Case Reports Asian J Transfus Sci. 2023;17(1):128\u201330.","journal-title":"Case Reports Asian J Transfus Sci."},{"issue":"1","key":"3100_CR23","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1002\/lt.20002","volume":"10","author":"H Haga","year":"2004","unstructured":"Haga H, Egawa H, Shirase T, Miyagawa A, Sakurai T, Minamiguchi S, et al. Periportal edema and necrosis as diagnostic histological features of early humoral rejection in ABO-incompatible liver transplantation. Liver Transpl. 2004;10(1):16\u201327.","journal-title":"Liver Transpl"}],"container-title":["Surgery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00595-025-03100-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00595-025-03100-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00595-025-03100-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T07:20:01Z","timestamp":1758180001000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00595-025-03100-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,22]]},"references-count":23,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["3100"],"URL":"https:\/\/doi.org\/10.1007\/s00595-025-03100-3","relation":{},"ISSN":["0941-1291","1436-2813"],"issn-type":[{"value":"0941-1291","type":"print"},{"value":"1436-2813","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,22]]},"assertion":[{"value":"10 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}